Hostname: page-component-745bb68f8f-grxwn Total loading time: 0 Render date: 2025-01-21T06:22:08.508Z Has data issue: false hasContentIssue false
  • English
  • Français

Reply

Published online by Cambridge University Press:  02 January 2015

Peter N.R. Heseltine
Peter N.R. Heseltine*
Affiliation:
Department of Health Services, UCLA Medical Center, Los Angeles, California
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Departments
Information
Infection Control & Hospital Epidemiology , Volume 6 , Issue 6 , June 1985 , pp. 216 - 217
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1985

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Szmuness, W, Stevens, CE, Harley, EJ, et al: Hepatitis B vaccine: Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980;303:833–841.Google Scholar
2.Francis, DP, Hadler, SC, Thompson, SE, et al: The prevention of hepatitis B with vaccine. Report of the Centers for Disease Control multi-center efficacy trial among homosexual men. Ann Inlern Med 1982;97:362–366.Google Scholar
3.Schaaff, DM, Lender, M, Snedeker, P, et al: Hepatitis B vaccine in a hospital. Ann Intern Med 1984; 101:720–720.Google Scholar
4.Strickler, AC, Kibsey, PC, Vellend, H: Seroconversion rates with hepatitis B vaccine [Letter]. Ann Intern Med 1984; 101:564.Google Scholar
5.Centers for Disease Control: Suboptimal response to hepatitis vaccine given by injection into the buttock. MMWR 1985; 34:105–105.Google Scholar
6.Centers for Disease Control: General recommendation on immunization. MMWR 1983; 32:1–16.Google Scholar
7.Krugman, S, Holey, HP Jr, Davidson, M. et al: Immunogenic effect of inactivated hepatitis B vaccine: Comparison of 20 microgram and 40 microgram doses. J Med Virol 1981; 8:119–121.Google Scholar
8.McLean, AA, Shaw, R Jr: Hepatitis B vaccine [Letter]. Ann Intern Med 1984; 101:564.Google Scholar
9.Zulek, G, Lorbeer, B, Jilg, W, et al: Persistence of anti-HB, after intradermal inoculation of reduced doses of hepatitis B vaccine. Lancet 1984; 2(8409):983–984.Google Scholar